Related Experiment Video
Updated: Jun 16, 2026

07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.6K
Rethinking Radiation Therapy for Perineural Invasion in Oral Cancer: Does More Coverage Improve Outcomes?
Sarbani Ghosh Laskar1, Anuj Kumar1, Ashwini Adhau1
1Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Cancer Medicine
|August 12, 2025
Summary
Adjuvant radiotherapy for oral squamous cell carcinoma with perineural invasion (PNI-OSCC) may not require expanded volumes. Personalized planning based on PNI extent and high-risk features is key for better outcomes.
Area of Science:
- Oncology
- Radiotherapy
- Oral Cancer Research
Background:
- Perineural invasion (PNI) in oral squamous cell carcinoma (OSCC) correlates with aggressive disease and reduced survival.
- Adjuvant radiotherapy (RT) is standard for PNI-positive OSCC, but optimal target volume definition is unclear.
Purpose of the Study:
- To evaluate the impact of RT target volume on recurrence and survival in PNI-positive OSCC.
- To identify prognostic factors influencing outcomes in PNI-positive OSCC patients.
Main Methods:
- Retrospective analysis of 103 PNI-positive OSCC patients treated with surgery and adjuvant RT (with or without chemotherapy).
- Recurrence patterns (in-field, marginal, out-of-field) and survival outcomes (OS, DFS) were assessed.
- Prognostic factors were analyzed using univariate and multivariate models.
Main Results:
- The 2-year overall survival (OS) and disease-free survival (DFS) were 63% and 57%, respectively.
- In-field recurrences were common (70% of local failures), with no skull base recurrences despite conservative RT volumes.
- Extensive PNI, large nerve involvement, advanced tumor stage (T3/T4), extranodal extension (ENE), and depth of invasion >10mm were associated with poorer outcomes.
Conclusions:
- Expanding RT volumes to encompass entire cranial nerve pathways may not enhance outcomes and could increase toxicity.
- Personalized RT planning, considering PNI extent, nerve involvement, and other risk factors, is crucial for optimizing treatment in PNI-positive OSCC.
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

